条件致死性分析揭示了抗癌作用机制和药物营养物相互作用
Kyle M Flickinger1,2, Kelli M Wilson3, Nicholas J Rossiter4
1Morgridge Institute for Research, Madison, WI 53715, USA.
Science advances
|October 4, 2024
概括
癌症药物发现需要更好的实验室条件. 这项研究使用人体等离子体介质 (HPLM) 发现新的药物营养相互作用和机制,揭示了布里武丁.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 人类癌症药物敏感性因基因型和血统而异.
- 传统的细胞培养基不能准确地反映人类血液中的代谢物水平.
- 这限制了有效的癌症治疗方法的发现.
研究的目的:
- 通过使用更具生理相关性的细胞培养基来研究药物疗效.
- 确定癌细胞中的新药-营养物相互作用和作用机制.
- 探索条件致死性作为一种药物发现战略.
主要方法:
- 在传统介质和人体等离子体介质 (HPLM) 中进行化学药物选.
- 在不同的媒介中比较复合活动,以确定条件表型.
- 分析媒体组件以将表型与特定营养物质联系起来,例如核酸合成基质.
- 研究了抗病毒药物布里武丁在癌细胞中的作用机制.
- 利用基因基本性数据来识别潜在的非目标效应.
主要成果:
- 已确定具有条件抗癌活性的化合物集,包括非瘤药物.
- 通过比较介质组件,将条件表型与核酸合成基质联系起来.
- 描述了布里武丁的双重机制:通过向单碳代谢酶,降低叶酸的细胞生长受损.
- 发现证据表明,其他药物的条件表型可能是由于目标外效应造成的.
结论:
- 人体等离子体媒介 (HPLM) 对于发现上下文依赖的药物活动至关重要.
- 药物-营养物相互作用和作用机制可以通过条件致死性选来确定.
- 布里武丁在低叶酸条件下通过向单碳代谢表现出选择性毒性.
- 这种方法为发现癌症药物和理解它们的机制提供了总体策略.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
3.9K
相关概念视频
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K